GlassScriptPhysician profile
Jignesh H Shah
NPI 1871741751
$7,159.01
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $244 · 2022: $212 · 2023: $4,615 · 2024: $1,843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,700 · Food and Beverage: $618 · Travel and Lodging: $101 · Education: $39.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,700.00 |
| Food and Beverage | $617.87 |
| Travel and Lodging | $100.87 |
| Education | $39.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $6,171.18 | 2019-2024 | Farxiga |
| Vifor Pharma, INC. | $263.14 | 2020-2024 | Veltassa |
| Mallinckrodt Enterprises LLC | $141.82 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $113.86 | 2019-2020 | |
| Glaxosmithkline, LLC. | $96.98 | 2023 | Benlysta |
| Medtronic Vascular, INC. | $82.50 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $71.06 | 2023-2024 | |
| Mallinckrodt Hospital Products INC. | $65.99 | 2022 | |
| Amgen INC. | $52.00 | 2019-2022 | |
| Ani Pharmaceuticals, INC. | $32.30 | 2023 | Purified Cortrophin Gel |
| Angiodynamics, INC. | $25.52 | 2020 | |
| Opko Pharmaceuticals, LLC | $19.08 | 2019 | |
| Tandem Diabetes Care, INC. | $12.51 | 2022 | |
| Allergan, INC. | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jignesh Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.